![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
C12N 15/13 | (2006.01) | ||
C07K 16/18 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 16/28 | (2006.01) |
(11) | Number of the document | 3370768 |
(13) | Kind of document | T |
(96) | European patent application number | 16862773.5 |
Date of filing the European patent application | 2016-11-01 | |
(97) | Date of publication of the European application | 2018-09-12 |
(45) | Date of publication and mention of the grant of the patent | 2022-01-12 |
(46) | Date of publication of the claims translation | 2022-05-25 |
(86) | Number | PCT/US2016/059833 |
Date | 2016-11-01 |
(87) | Number | WO 2017/079112 |
Date | 2017-05-11 |
(30) | Number | Date | Country code |
201562250095 P | 2015-11-03 | US |
(72) |
VERONA, Raluca , US
POWERS, Gordon , US
SABINS, Nina Chi , US
DEANGELIS, Nikki A. , US
SANTULLI-MAROTTO, Sandra , US
WIEHAGEN, Karla R. , US
WU, Sheng-Jiun , US
FERRANTE, Catherine , US
UBANI, Enrique-Zudaire , US
|
(73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Antikūnai, specifiškai surišantys PD-1, ir jų panaudojimas |
ANTIBODIES SPECIFICALLY BINDING PD-1 AND THEIR USES |
Payment date | Validity (years) | Amount | |
2024-10-04 | 9 | 208.00 EUR |
2025-11-01 |